Imperial College London
Portrait Picture

ProfessorDariusArmstrong-James

Faculty of Medicine, Department of Infectious Disease

Professor of Infectious Diseases and Medical Mycology
 
 
 
//

Contact

 

d.armstrong

 
 
//

Location

 

Flowers buildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Abdolrasouli:2018:10.1111/myc.12789,
author = {Abdolrasouli, A and Bercusson, AC and Rhodes, JL and Hagen, F and Buil, JB and Tang, AYY and de, Boer LL and Shah, A and Milburn, AJ and Elborn, JS and Jones, AL and Meis, JF and Fisher, MC and Schelenz, S and Simmonds, NJ and Armstrong-James, D},
doi = {10.1111/myc.12789},
journal = {Mycoses},
pages = {665--673},
title = {Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosis},
url = {http://dx.doi.org/10.1111/myc.12789},
volume = {61},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Infections caused by Rasamsonia argillacea complex have been reported in various clinical settings. Cystic fibrosis (CF) is one of the main underlying conditions. An observational cohort study of CF patients with Rasamsonia in respiratory samples was conducted. Eight isolates from six patients were identified as R. argillacea complex and tested for antifungal susceptibility. All isolates had high MICs to voriconazole and posaconazole and low MECs to echinocandins. Four patients experienced lung function decline in the year preceding first Rasamsonia isolation. This continued in the year following first isolation in three out of four cases. Antifungal therapy was initiated in two patients, to which only one exhibited a clinical response. Three out of six patients died within three years of isolating Rasamsonia. Genotyping suggests that similar genotypes of Rasamsonia can persist in CF airways. Consistent with other fungi in CF, the clinical impact of airway colonization by Rasamsonia is variable. In certain patients, Rasamsonia may be able to drive clinical decline. In others, though a clear impact on lung function may be difficult to determine, the appearance of Rasamsonia acts as a marker of disease severity. In others it does not appear to have an obvious clinical impact on disease progression.
AU  - Abdolrasouli,A
AU  - Bercusson,AC
AU  - Rhodes,JL
AU  - Hagen,F
AU  - Buil,JB
AU  - Tang,AYY
AU  - de,Boer LL
AU  - Shah,A
AU  - Milburn,AJ
AU  - Elborn,JS
AU  - Jones,AL
AU  - Meis,JF
AU  - Fisher,MC
AU  - Schelenz,S
AU  - Simmonds,NJ
AU  - Armstrong-James,D
DO  - 10.1111/myc.12789
EP  - 673
PY  - 2018///
SN  - 0933-7407
SP  - 665
TI  - Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosis
T2  - Mycoses
UR  - http://dx.doi.org/10.1111/myc.12789
UR  - https://www.ncbi.nlm.nih.gov/pubmed/29702751
UR  - http://hdl.handle.net/10044/1/59290
VL  - 61
ER  -
Download